Letrozole Therapy for IVF/ET: Effects on Multiple Pregnancy and Treatment Burden
来曲唑治疗 IVF/ET:对多胎妊娠和治疗负担的影响
基本信息
- 批准号:7293189
- 负责人:
- 金额:$ 29.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-07 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdherenceAdhesionsAdverse eventAdvertisementsAdvisory CommitteesAffectAfricanAfrican AmericanAgeAge-YearsAgonistAgreementAirAlcohol or Other Drugs useAllyAmbulatory Care FacilitiesAmbulatory MonitoringAmericanAncillary StudyAnemiaAnorexiaApplication procedureArchivesAreaAromatase InhibitorsArtsAsiansAspirinAssisted Reproductive TechnologyAttentionAwardBackBeesBehaviorBehavior TherapyBiologicalBiological MarkersBiometryBiopsyBirthBirth RateBiteBlood CirculationBlood Specimen CollectionBoxingBreastCalciumCaliberCaringCatchment AreaCategoriesCathetersCaucasiansCaucasoid RaceCertificationCervix UteriCessation of lifeChairpersonCharacteristicsChargeChildChild health careChildren&aposs Oncology GroupChlamydiaCitiesCitrateCitratesClinicClinicalClinical DataClinical InformaticsClinical InvestigatorClinical Nursing ResearchClinical ResearchClinical TrialsClinical Trials DesignClinical and Translational Science AwardsClinical trial protocol documentClomipheneClomiphene CitrateCodeCognitive TherapyCollaborationsCollectionColombiaColorColorectal CancerCommitCommunicationCommunitiesCommunity OutreachComplexComputer softwareComputersConditionConduct Clinical TrialsConfidentialityConsentConsent FormsConsultationsContractsCost SavingsCounselingCountyCouplesCryopreservationDailyDataData AnalysesData CollectionData Coordinating CenterData ElementData QualityData ReportingData SecurityDatabasesDate/TimeDental SchoolsDepthDevelopmentDiagnosisDiagnosticDiet ModificationDietary FatsDisadvantagedDisastersDiscipline of obstetricsDiseaseDoctor of MedicineDoctor of PhilosophyDoseDouble-Blind MethodDown-RegulationDropsDrug FormulationsDrug IndustryDrug KineticsEconomic BurdenEducationEducational AssessmentEducational InterventionEducational MaterialsEffectivenessEffectiveness of InterventionsElectronicsEligibility DeterminationEmbryoEmbryo TransferEnd PointEndocrineEndometrialEnrollmentEnsureEnvironmentEpidemiologyEpidemiology, OtherEquilibriumEquipmentEstrogensEthnic OriginEthnic groupEvaluationEventFacultyFailureFamily health statusFellowshipFemaleFemale infertilityFertilityFertilizationFertilization in VitroFiberFire - disastersFloridaFoundationsFrequenciesFundingFutureGelGenderGenerationsGeneric DrugsGenetic Crossing OverGiftsGoalsGonadotropin Hormone Releasing HormoneGonadotropinsGonal-FGonorrheaGrantGreater sac of peritoneumGroup MeetingsGroupingGuidelinesGynecologistGynecologyHealthHealth Care Seeking BehaviorHealth InsuranceHealth Insurance Portability and Accountability ActHealth Maintenance OrganizationsHealth PersonnelHealth PolicyHealth PromotionHealth SciencesHealth ServicesHealth Services AccessibilityHealth Services ResearchHealth educationHealth systemHealthcareHealthy People 2010HemorrhageHeterosexualsHip FracturesHirsutismHispanicsHormone ReceptorHormonesHospital DepartmentsHourHumanHuman DevelopmentHuman Follicle Stimulating HormoneHuman ResourcesHydrate Nafarelin AcetateImageIncidenceIndividualIndustryInfectionInfection preventionInfertilityInformaticsInformation SystemsInhalation TherapyInstitutesInstitutionInternationalInternetInterventionIntervention TrialInterviewIntranetInvasiveInvestigationInvestigational DrugsIronJointsLabelLaboratoriesLaboratory ResearchLeadLeadershipLeftLegalLeiomyomaLetrozoleLettersLeuprolide AcetateLifeLinkLive BirthLocal Area NetworksLocationLogistic RegressionsLong-Term EffectsLongevityLow incomeLuteal PhaseMagnetic Resonance ImagingMailsMaintenanceMale InfertilityMalignant NeoplasmsManualsMapsMass ScreeningMaster of Public HealthMeasuresMedia CampaignMedicaidMedicalMedical InformaticsMedicineMenopauseMenorrhagiaMenstruation DisturbancesMetforminMethodologyMethodsMetrorrhagiaMexicanMexican AmericansMicrocomputersMidwifeMinorityMissionModelingMonitorMorbidity - disease rateMothersMotivationMulti-Institutional Clinical TrialMulticenter StudiesMulticenter TrialsMultifetal Pregnancy ReductionMultiple Birth OffspringMultiple PregnancyNafarelinNamesNational Cancer InstituteNewspapersNorethindroneNot Hispanic or LatinoNumbersNursesNursing FacultyNursing ResearchNursing SchoolsObesityObservational StudyObstetrics DepartmentsOffice VisitsOne-Step dentin bonding systemOnline SystemsOocytesOperative Surgical ProceduresOpticsOral AdministrationOutcomeOutcome StudyOvarianOvarian StimulationsOvaryOveractive BladderOvulationOvulation InductionPaperParticipantPatient CarePatient RecruitmentsPatient Self-ReportPatient currently pregnantPatientsPatternPediatric Oncology GroupPelvic PainPelvisPersonal SatisfactionPharmaceutical PreparationsPharmacologic SubstancePhasePhysiciansPiperPituitary GlandPlacebo ControlPlacebosPlayPoliciesPolycystic Ovary SyndromePolypsPopulationPopulation StudyPositron-Emission TomographyPostdoctoral FellowPostmenopausePostoperative PeriodPredispositionPregnancyPregnancy RatePregnancy lossPremature Ovarian FailurePrematurity of fetusPreventionPrevention interventionPreventivePrimary Care PhysicianPrincipal InvestigatorPrintingProceduresProcessProductionProfessional EducationProfessional counselorProgesterone ReceptorsProgestin TherapyProgestinsProtocols documentationPsychiatryPsychosocial FactorPublic HealthPublicationsQualifyingQuality ControlRaceRadioRandomizedRandomized Clinical TrialsRangeRateReadingRecording of previous eventsRecordsRecoveryRecruitment ActivityRecurrenceRegistered nurseReportingReproductionReproductive EndocrinologyReproductive HealthReproductive MedicineResearchResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResistanceResource SharingResourcesRiskRisk BehaviorsRoleRouteRunningSASSafetySample SizeSan Antonio Cancer InstituteScanningScheduleSchool NursingSchoolsScienceSecureSecuritySecurity MeasuresSelf AdministrationSeminalSeriesServicesSexual HealthSexually Transmitted DiseasesSiteSocial SciencesSodiumSolutionsSomatotropin-Releasing HormoneSourceSouth TexasSpecific qualifier valueSpecimenSpermatocidal AgentsStandards of Weights and MeasuresStrategic PlanningStressStress Urinary IncontinenceStructureStudentsStudy SubjectSuperovulationSupplementationSymptomsSyndromeSystemSystems AnalysisTechniquesTechnologyTelephoneTelephone NumberTelevisionTest ResultTestingTexasTherapy Clinical TrialsThird-Party PayerTimeTimeLineTitleTrainingTraining ActivityTranscranial magnetic stimulationTreatment CostTreatment EfficacyTreatment ProtocolsTrichomonas vaginalisTwin Multiple BirthUltrasonographyUninsuredUnited StatesUnited States Dept. of Health and Human ServicesUnited States National Institutes of HealthUniversitiesUniversity HospitalsUpdateUrge IncontinenceUrinary IncontinenceUrologistUrologyUterine FibroidsVaccinationVaginaVenous blood samplingVertebral columnVirusVitamin DVotingWomanWomen&aposs HealthWorkWorld Health OrganizationWritingbaseblindbone losscancer preventioncardiovascular disorder riskcatalystcaucasian Americanclinical research sitecollegecomputer networkcomputerized data processingcomputing resourcesconceptcostdata managementdatabase designdesigndesiredisabilitydisability burdendisorder preventiondistributed dataefficacy trialeligible participantendometriosisepidemiology studyexperiencefallsfirewallfollow-upfunctional grouphealth disparityhormone therapyhuman subjectimprovedinnovationinterdisciplinary collaborationinterestintrauterine inseminationlow socioeconomic statusmalemedical schoolsmembermetropolitanmicrobicidemicturition urgencymortalitymultidisciplinarynewsnoveloptical character recognitionoptical fiberorganizational structureovarian neoplasmpressurepreventprofessorprognosticprogramsproliferative phase Menstrual cycleprospectivepsychologicquality assuranceranpirnasereproductiveresearch clinical testingresearch studyresponsesample collectionsatisfactionsizesocialstillbirthsubcutaneoussuccesssymposiumsyntaxtooltraffickingtransmission processtreatment durationtreatment effecttrendviolence preventionvirtualwide area network
项目摘要
DESCRIPTION (provided by applicant): This application is written in response to RFA-HD-06-008 to participate as a Clinical Site in an ongoing multicenter cooperative program designed to conduct clinical studies investigating problems in reproductive medicine. The application directly addresses the mission of the Reproductive Sciences Branch to ensure the birth of healthy, wanted babies through studies on human fertility and infertility. The long term objectives of the proposed project are to reduce the incidence of multiple pregnancy associated with assisted reproductive technology (ART), to reduce the incidence of excess embryo production and embryo cryopreservation associated with ART, and to reduce the burden on patients of ART therapy. Over 100,000 cycles of ART treatment are performed each year in the US, and ART is now responsible for 1% of all births. Advances in ART have increased its efficacy, but have also led to a large increase in the incidence of multiple pregnancies. The public health impact of ART associated multiple pregnancies cannot be overstated. The majority of ART cycles in the US employ complex treatment regimens entailing self administration of multiple parenteral drugs and intensive outpatient monitoring. These regimens facilitate the creation of multiple embryos, which promotes the transfer and cryopreservation of excess embryos. The proposed project aims to address the shortcomings of conventional ART therapy by examining via a randomized clinical trial design an alternative ovarian stimulation regimen based on the oral administration of the aromatase inhibitor letrozole and minimal monitoring. The specific aims of the project are to: 1) compare the incidence of multiple pregnancies in letrozole ART cycles with the incidence in conventional ART, 2) determine the incidence of embryo cryopreservation in the two treatment regimens, 3) compare the cumulative live born delivery rate per patient derived from two cycles of letrozole ART compared to one cycle of conventional ART, 4) examine the cumulative cost of two cycles of letrozole ART compared to the cost of a single cycle of conventional ART, and 5) compare self-reported levels of treatment burden and participant concerns between the two regimens. It is hypothesized that the cost savings and reduced treatment burden associated with letrozole therapy compared to conventional ART will allow patients to undergo two cycles of letrozole based ART, which will result in a similar live born delivery rate, a significantly lower incidence of multiple pregnancy and a significantly lower incidence of embryo cryopreservation. The relevance of the project derives from its potential to reduce multiple pregnancies with their attendant costs and risk of death and disability. The proposed examination of treatment costs is relevant given the problem of access to ART care, which limits appropriate utilization in the US. Finally, the project addresses relevant social and ethical concerns regarding embryo cryopreservation.
描述(由申请人提供):本申请是为了响应RFA-HD-06-008,作为临床站点参与正在进行的多中心合作计划,旨在进行临床研究,调查生殖医学中的问题。该应用程序直接涉及生殖科学处的使命,即通过对人类生育和不孕不育的研究,确保健康、想要的婴儿的出生。拟议项目的长期目标是减少与辅助生殖技术(ART)相关的多胎妊娠的发生率,减少与ART相关的过多胚胎生产和胚胎冷冻的发生率,并减轻ART治疗患者的负担。在美国,每年进行超过10万个周期的抗逆转录病毒治疗,现在抗逆转录病毒治疗占所有新生儿的1%。抗逆转录病毒疗法的进步提高了其疗效,但也导致多胎妊娠的发生率大幅增加。抗逆转录病毒治疗相关的多胎妊娠对公众健康的影响怎么强调都不为过。美国的大多数抗逆转录病毒治疗周期采用复杂的治疗方案,包括多种非肠道药物的自我给药和密集的门诊监测。这些方案有助于产生多个胚胎,从而促进多余胚胎的移植和冷冻保存。该项目旨在解决传统ART疗法的缺点,通过随机临床试验设计,研究一种基于口服芳香酶抑制剂来曲唑和最低限度监测的替代卵巢刺激方案。该项目的具体目标是:1)比较来曲唑抗逆转录病毒治疗周期中多胎妊娠的发生率与传统抗逆转录病毒疗法的发生率,2)确定两种治疗方案中胚胎冷冻保存的发生率,3)比较来自两个来曲唑抗逆转录病毒治疗周期和一个传统抗逆转录病毒疗法周期的每个患者的累计活产率,4)检查两个周期来曲唑抗逆转录病毒疗法的累积成本与传统抗逆转录病毒疗法单周期的成本,以及5)比较两种治疗方案之间自我报告的治疗负担水平和参与者的担忧。据推测,与传统的ART相比,与来曲唑治疗相关的成本节约和治疗负担将允许患者接受两个周期的来曲唑ART,这将导致类似的活产分娩率,多胎妊娠的发生率显著降低,胚胎冷冻保存的发生率显著降低。该项目的相关性源于它有可能减少多胎妊娠及其随之而来的费用和死亡和残疾风险。考虑到获得抗逆转录病毒治疗的问题,拟议的治疗费用审查是相关的,这限制了美国的适当利用。最后,该项目解决了有关胚胎冷冻保存的相关社会和伦理问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT G BRZYSKI其他文献
ROBERT G BRZYSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT G BRZYSKI', 18)}}的其他基金
Letrozole Therapy for IVF/ET: Effects on Multiple Pregnancy and Treatment Burden
来曲唑治疗 IVF/ET:对多胎妊娠和治疗负担的影响
- 批准号:
7935596 - 财政年份:2009
- 资助金额:
$ 29.2万 - 项目类别:
CLINICAL TRIAL: THE EFFECTS OF CLOMIPHENE CITRATE AND LETROZOLE IN WOMEN WITH PC
临床试验:克罗米芬柠檬酸盐和来曲唑对患有 PC 的女性的影响
- 批准号:
7718738 - 财政年份:2008
- 资助金额:
$ 29.2万 - 项目类别:
THE EFFECTS OF CLOMIPHENE CITRATE AND LETROZOLE IN WOMEN WITH PCOS
克罗米芬柠檬酸盐和来曲唑对多囊卵巢综合征女性的影响
- 批准号:
7627548 - 财政年份:2007
- 资助金额:
$ 29.2万 - 项目类别:
THE GENETIC INHERITANCE OF POLYCYSTIC OVARY SYNDROME
多囊卵巢综合症的基因遗传
- 批准号:
7627547 - 财政年份:2007
- 资助金额:
$ 29.2万 - 项目类别:
Letrozole Therapy for IVF/ET: Effects on Multiple Pregnancy and Treatment Burden
来曲唑治疗 IVF/ET:对多胎妊娠和治疗负担的影响
- 批准号:
7494440 - 财政年份:2007
- 资助金额:
$ 29.2万 - 项目类别:
Letrozole Therapy for IVF/ET: Effects on Multiple Pregnancy and Treatment Burden
来曲唑治疗 IVF/ET:对多胎妊娠和治疗负担的影响
- 批准号:
7668597 - 财政年份:2007
- 资助金额:
$ 29.2万 - 项目类别:
Letrozole Therapy for IVF/ET: Effects on Multiple Pregnancy and Treatment Burden
来曲唑治疗 IVF/ET:对多胎妊娠和治疗负担的影响
- 批准号:
8469689 - 财政年份:2007
- 资助金额:
$ 29.2万 - 项目类别:
Letrozole Therapy for IVF/ET: Effects on Multiple Pregnancy and Treatment Burden
来曲唑治疗 IVF/ET:对多胎妊娠和治疗负担的影响
- 批准号:
7906941 - 财政年份:2007
- 资助金额:
$ 29.2万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 29.2万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 29.2万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 29.2万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 29.2万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 29.2万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 29.2万 - 项目类别:














{{item.name}}会员




